Ac-225-RYZ-401

The role of AI in breast cancer diagnosis and treatment Reva K. Basho, M.D., from Ellison Medical Institute and Criterium’s Academic Breast Cancer Consortium (ABRCC), discusses the role of AI in breast cancer diagnosis and treatment: “Our improved imaging tools, along with AI-based image analysis that helps radiologists review images, lead to faster, more accurate diagnoses so that we can initiate treatment quickly.” Learn about new technologies for breast cancer diagnosis and treatment Exploring stereotactic body radiation therapy (SBRT) over conventional radiation therapy for spine bone metastases Charles C. Hsu, M.D., Ph.D. from the University of Arizona Cancer Center and Criterium’s Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC) co-authored a paper exploring stereotactic body radiation therapy (SBRT) over conventional radiation therapy for spine bone metastases View the publication New Phase 1 trial of next-generation targeted therapy for neuroendocrine tumors (NETs) and other solid tumors The first three patients in the world have been treated with RYZ401, a radiopharmaceutical therapy for neuroendocrine tumors (NETs) and other solid tumors delivering radiation to cancer cells while sparing healthy tissue. Heloisa Soares, M.D., Ph.D. from Huntsman Cancer Institute and Criterium’s Academic GI Cancer Consortium (AGICC) is leading the Phase 1 trial. Learn more about this new radiopharmaceutical therapy trial New study results exploring novel KRAS-targeted treatments with promising efficacy in early-phase studies of patients with pancreatic ductal adenocarcinoma (PDAC) Anup Kasi, M.D., M.PH., of the University of Kansas Medical Center and Criterium’s Academic GI Cancer Consortium (AGICC), presented results of a study exploring novel KRAS-targeted treatments, demonstrating promising efficacy in early-phase studies of patients with pancreatic ductal adenocarcinoma (PDAC) and KRASG12D mutations. Learn about the study results New podcast episode explores advances in lung cancer research and patient care, including immunotherapy and rapid molecular testing In a recent podcast, Lei Deng, MD, from Criterium’s Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC) and the Fred Hutch Cancer Center discusses advances in lung cancer research and patient care. Listen to the podcast